Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 90 days matching "Li-Fraumeni syndrome"

Clinical trialCLINICALTRIALSMar 26

Trial Now Recruiting: Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System (NCT01143454)

Researchers at the National Heart, Lung, and Blood Institute are looking for 5,000 people who have or might have diseases that affect their heart, blood vessels, or metabolism. Participants will have blood tests and heart function tests tailored to their specific condition. Both people with these conditions and healthy people can join to help scientists understand why some people develop heart disease.

WHY IT MATTERSThis large-scale study is actively recruiting and may help identify new risk factors for heart disease in people with rare metabolic, inflammatory, and genetic conditions like Li-Fraumeni Syndrome and cardiomyopathy.
You can act on thisLi-Fraumeni SyndromeCardiomyopathyAtherosclerosisRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases